Sleep Apnea Cardiovascular Endpoints Study (SAVE)
Save is a multi-centre, randomised, controlled trial to determine the effects of nasal continuous positive airway pressure (CPAP) in preventing cardiovascular (CV) disease in high risk patients with moderate-severe obstructive sleep apnea (OSA). See Study Overview.
A pivotal research programme involving sleep and CV medicine experts aimed at producing high level evidence to inform clinical decision making and future health policy in a large and increasing area of global disease burden.
Invitations are sought from industry, professional groups and scientific funding bodies for partnerships with the academic group on this project.
SAVE Researcher Area
Use the links below to login:
SAVE DatabasePlatinum Sponsors
